Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 25.24
+0.86 (3.53%)
Aug 10, 2026, 3:04 PM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 21.53 billion as of August 10, 2026. Its market cap has increased by 4.19% in one year.
Market Cap
21.53B
Enterprise Value
23.40B
Revenue
955.53M
Ranking
n/a
PE Ratio
238.38
Stock Price
25.24
ChartMarket Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 21.53B, an increase of 634.93%. That is a compound annual growth rate of 13.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 21.53B | 36.20% |
| Dec 31, 2025 | 15.81B | 38.87% |
| Dec 31, 2024 | 11.38B | -5.08% |
| Dec 29, 2023 | 11.99B | -22.75% |
| Dec 30, 2022 | 15.53B | 39.41% |
| Dec 31, 2021 | 11.14B | 88.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.91B |
| Livzon Pharmaceutical Group | 24.87B |
| Guangdong Zhongsheng Pharmaceutical | 24.29B |
| Hubei Jumpcan Pharmaceutical | 23.87B |
| Tasly Pharmaceutical Group | 23.48B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.18B |
| Jilin Aodong Pharmaceutical Group | 21.26B |
| Walvax Biotechnology | 21.02B |